PsyBio Therapeutics Corp.
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. The net income raised on -$4,886,063 over the previous period. Total operating expenses were $4,706,182.
Profit Margin
| 2018 | 0 | -39.85K | |
|---|---|---|---|
| 2020 | 0 | -6.43M | |
| 2021 | 0 | -11.01M | |
| 2022 | 0 | -4.88M |
PSYB.V Income Statement (2017 – 2022)
| 2022 | 2021 | 2020 | 2017 | |
|---|---|---|---|---|
Revenue | ||||
Revenue | 0 | 0 | 0 | 0 |
Cost of revenue | 50K | 62.5K | 1.53M | 0 |
Gross profit | -50K | -62.5K | -1.53M | 0 |
Operating exp. | ||||
Research and development | 390.13K | 622.79K | 54.54K | 0 |
Selling and marketing | 0 | 0 | 3.85K | 0 |
Total operating expenses | 4.70M | 9.60M | 4.90M | 39.85K |
Operating income | -4.72M | -8.22M | -6.43M | -39.84K |
Other income (expenses), net | -108.82K | -1.35M | 353 | -3 |
Income before tax | -4.88M | -11.01M | -6.43M | -39.85K |
Income tax expense | 49.16K | 0 | 0 | 0 |
Net income | -4.88M | -11.01M | -6.43M | -39.85K |
Earnings per share | ||||
Basic EPS | -0.04 | -0.1 | -0.2 | -0.01 |
Diluted EPS | -0.04 | -0.1 | -0.2 | -0.01 |